The software will enable healthcare workers to perform dual screening of COVID-19 and lung diseases such as tuberculosis in remote and resource-challenged locations, and will benefit an estimated 62,500 people in the next 12–14 months.The software will enable healthcare workers to perform dual screening of COVID-19 and lung diseases such as tuberculosis in remote and resource-challenged locations, and will benefit an estimated 62,500 people in the next 12–14 months.Read More
